1. Home
  2. XENE vs PAYO Comparison

XENE vs PAYO Comparison

Compare XENE & PAYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • PAYO
  • Stock Information
  • Founded
  • XENE 1996
  • PAYO 2005
  • Country
  • XENE Canada
  • PAYO United States
  • Employees
  • XENE N/A
  • PAYO N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • PAYO EDP Services
  • Sector
  • XENE Health Care
  • PAYO Technology
  • Exchange
  • XENE Nasdaq
  • PAYO Nasdaq
  • Market Cap
  • XENE 2.4B
  • PAYO 2.5B
  • IPO Year
  • XENE 2014
  • PAYO N/A
  • Fundamental
  • Price
  • XENE $32.21
  • PAYO $6.48
  • Analyst Decision
  • XENE Strong Buy
  • PAYO Strong Buy
  • Analyst Count
  • XENE 11
  • PAYO 8
  • Target Price
  • XENE $54.82
  • PAYO $10.44
  • AVG Volume (30 Days)
  • XENE 1.5M
  • PAYO 2.6M
  • Earning Date
  • XENE 08-07-2025
  • PAYO 08-06-2025
  • Dividend Yield
  • XENE N/A
  • PAYO N/A
  • EPS Growth
  • XENE N/A
  • PAYO N/A
  • EPS
  • XENE N/A
  • PAYO 0.28
  • Revenue
  • XENE $7,500,000.00
  • PAYO $996,150,000.00
  • Revenue This Year
  • XENE N/A
  • PAYO $4.32
  • Revenue Next Year
  • XENE $253.71
  • PAYO $5.59
  • P/E Ratio
  • XENE N/A
  • PAYO $23.11
  • Revenue Growth
  • XENE N/A
  • PAYO 14.86
  • 52 Week Low
  • XENE $26.74
  • PAYO $5.03
  • 52 Week High
  • XENE $46.00
  • PAYO $11.29
  • Technical
  • Relative Strength Index (RSI)
  • XENE 50.43
  • PAYO 41.54
  • Support Level
  • XENE $31.22
  • PAYO $6.64
  • Resistance Level
  • XENE $33.51
  • PAYO $6.93
  • Average True Range (ATR)
  • XENE 1.24
  • PAYO 0.21
  • MACD
  • XENE 0.06
  • PAYO -0.01
  • Stochastic Oscillator
  • XENE 40.88
  • PAYO 8.89

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About PAYO Payoneer Global Inc.

Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.

Share on Social Networks: